Breaking News Instant updates and real-time market news.

AMGN

Amgen

$198.59

-0.02 (-0.01%)

09:03
08/29/18
08/29
09:03
08/29/18
09:03

Amgen: European Commission approves BLINCYTO

Amgen announced that the European Commission has approved an expanded indication for BLINCYTO as monotherapy for the treatment of pediatric patients aged one year or older with Philadelphia chromosome-negative CD19 positive B-cell precursor acute lymphoblastic leukemia, which is refractory or in relapse after receiving at least two prior therapies or in relapse after receiving prior allogeneic hematopoietic stem cell transplantation. The approval is based on results from the Phase 1/2 '205 study, an open-label, multicenter, single-arm trial which evaluated the efficacy and safety of BLINCYTO in pediatric patients with relapsed or refractory B-cell precursor ALL.

  • 12

    Sep

  • 26

    Sep

  • 17

    Oct

  • 22

    Oct

  • 09

    Nov

AMGN Amgen
$198.59

-0.02 (-0.01%)

07/27/18
JEFF
07/27/18
NO CHANGE
Target $220
JEFF
Buy
Amgen price target raised to $220 from $200 at Jefferies
Jefferies analyst Michael Yee raised his price target for Amgen to $220 saying the company last night reported "another strong quarter." He thinks Amgen shares "will go well north" of $200-$220 if the company can manage Neulasta biosimilar risk and "take the fears off the table." Yee keeps a Buy rating on the stock.
07/30/18
PIPR
07/30/18
NO CHANGE
PIPR
Arrowhead pullback a buying opportunity, says Piper Jaffray
Piper Jaffray analyst Edward Tenthoff said he would remain a buyer of Arrowhead Pharmaceuticals shares ahead of a "busy" second half of the year. The company could have five RNAi candidates in the clinic this year, and partner Amgen (AMGN) nominated AMG-890 as a clinical candidate that could begin clinical trials this year. Tenthoff reiterated an Overweight rating and $17 price target on Arrowhead shares.
08/07/18
STFL
08/07/18
INITIATION
Target $30
STFL
Buy
Alder Biopharmaceuticals initiated with a Buy at Stifel
Stifel analyst Paul Matteis initiated coverage of Alder BioPharmaceuticals with a Buy rating and $30 price target, calling it an attractive, differentiated "pure play" within the migraine antiCGRP prevention market. While Matteis acknowledges it "won't be easy" for Alder to compete with Amgen (AMGN), Novartis (NVS), Eli Lilly (LLY) and Teva (TEVA), he believes the unique profile of eptinezumab remains underappreciated and may allow it to capture meaningful, above consensus share of a large, emerging drug category.
08/08/18
LEER
08/08/18
NO CHANGE
LEER
Regeneron, Amgen most exposed to Medicare Part B changes, says Leerink
After the Centers for Medicare and Medicaid Services announced that Medicare Advantage plans will have the option in 2019 of applying step therapy for physician-administered and other Part B drugs for new patients, Leerink analyst Geoffrey Porges said the end goal is to create MA plan formularies that can be used as a tool to negotiate with pharmaceutical makers for lower drug prices. Among the stocks he covers, Porges identifies Regeneron (REGN) and Amgen (AMGN) as among those with the most exposure to increased competitive intensity in Part B. For Regeneron, he sees the news re-igniting speculation about the threat of biosimilars and substitution with compounded Avastin, while for Amgen the change means that preference for its growth factor products facing biosimilar competition is likely to be challenged, the analyst said. Regeneron shares are down 4.6% to $373.34 in morning trading, while Amgen is down 2.2% to $195.89.

TODAY'S FREE FLY STORIES

INO

Inovio

$5.05

0.22 (4.55%)

05:14
09/26/18
09/26
05:14
09/26/18
05:14
Recommendations
Inovio analyst commentary  »

Piper remains buyer of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

ATVI

Activision Blizzard

$80.50

-0.11 (-0.14%)

05:11
09/26/18
09/26
05:11
09/26/18
05:11
Recommendations
Activision Blizzard analyst commentary  »

Activision Blizzard price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNDM

TNDM

05:09
09/26/18
09/26
05:09
09/26/18
05:09
Recommendations
TNDM analyst commentary  »

Tandem Diabetes price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

LOXO

Loxo Oncology

$166.80

3.73 (2.29%)

, BPMC

Blueprint Medicines

$75.20

3.64 (5.09%)

05:06
09/26/18
09/26
05:06
09/26/18
05:06
Recommendations
Loxo Oncology, Blueprint Medicines analyst commentary  »

Loxo RET inhibitor still…

LOXO

Loxo Oncology

$166.80

3.73 (2.29%)

BPMC

Blueprint Medicines

$75.20

3.64 (5.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Nov

  • 27

    Nov

MTB

M&T Bank

$168.53

-1.6 (-0.94%)

05:02
09/26/18
09/26
05:02
09/26/18
05:02
Upgrade
M&T Bank rating change  »

M&T Bank upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STM

STMicroelectronics

$19.10

0.07 (0.37%)

04:59
09/26/18
09/26
04:59
09/26/18
04:59
Upgrade
STMicroelectronics rating change  »

STMicroelectronics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIAB

Viacom

$32.48

-0.11 (-0.34%)

, VIA

Viacom

$34.80

0.05 (0.14%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Upgrade
Viacom, Viacom, CBS rating change  »

Viacom upgraded to Buy…

VIAB

Viacom

$32.48

-0.11 (-0.34%)

VIA

Viacom

$34.80

0.05 (0.14%)

CBS

CBS

$56.54

-0.07 (-0.12%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

XOXO

XO Group

$34.91

7.29 (26.39%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Downgrade
XO Group rating change  »

XO Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRVL

Marvell

$18.58

-0.31 (-1.64%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Marvell management to meet with UBS »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 08

    Oct

04:55
09/26/18
09/26
04:55
09/26/18
04:55
General news
Breaking General news story  »

FOMC Forecasts to be…

EOG

EOG Resources

$125.67

1.675 (1.35%)

, WFT

Weatherford

$2.73

0.035 (1.30%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Credit Suisse to hold a non tour »

4th Annual Oil & Gas…

EOG

EOG Resources

$125.67

1.675 (1.35%)

WFT

Weatherford

$2.73

0.035 (1.30%)

OXY

Occidental Petroleum

$81.31

0.57 (0.71%)

COG

Cabot Oil & Gas

$23.24

0.035 (0.15%)

NFX

Newfield Exploration

$29.24

-0.52 (-1.75%)

FRAC

Keane Group

$12.86

0.27 (2.14%)

MRO

Marathon Oil

$22.50

0.17 (0.76%)

MUR

Murphy Oil

$32.55

-0.21 (-0.64%)

SLB

Schlumberger

$62.54

0.955 (1.55%)

APC

Anadarko

$66.83

0.82 (1.24%)

NOV

National Oilwell

$43.44

-0.04 (-0.09%)

RIG

Transocean

$13.98

0.19 (1.38%)

HES

Hess Corp.

$71.61

-0.41 (-0.57%)

NBR

Nabors Industries

$6.14

-0.085 (-1.37%)

OAS

Oasis Petroleum

$13.92

0.26 (1.90%)

COP

ConocoPhillips

$78.11

1.05 (1.36%)

APA

Apache

$47.78

0.29 (0.61%)

BHGE

Baker Hughes

$33.48

0.64 (1.95%)

HA

Hawaiian Holdings

$38.75

-0.35 (-0.90%)

CVX

Chevron

$123.38

0.72 (0.59%)

FTI

TechnipFMC

$32.55

0.79 (2.49%)

HAL

Halliburton

$41.36

0.28 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 29

    Sep

  • 01

    Oct

  • 04

    Oct

  • 05

    Oct

  • 19

    Oct

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 29

    Oct

  • 02

    Nov

FBP

First BanCorp

$9.01

0.085 (0.95%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
First BanCorp management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 28

    Sep

  • 25

    Oct

PREKF

PrairieSky Royalty

$0.00

(0.00%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
PrairieSky Royalty management to meet with TD Securities »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

COWN

Cowen Group

$16.50

0.5 (3.13%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Cowen Group management to meet with Sandler O'Neill »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 01

    Oct

  • 28

    Oct

TSLA

Tesla

$301.05

1.44 (0.48%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Tesla management to meet with Evercore ISI »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 29

    Oct

  • 13

    Nov

ENLC

EnLink Midstream

$16.20

-0.05 (-0.31%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
EnLink Midstream management to meet with RBC Capital »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

COO

Cooper Companies

$272.84

3.38 (1.25%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Cooper Companies management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BCOR

Blucora

$36.35

0.5 (1.39%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Blucora management to meet with Benchmark »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

UBS

UBS

$16.34

-0.06 (-0.37%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
UBS management to meet with UBS »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 01

    Oct

MYGN

Myriad Genetics

$46.63

-0.28 (-0.60%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Myriad Genetics management to meet with Stephens »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 06

    Nov

CDAY

Ceridian

$41.05

-1.24 (-2.93%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Ceridian management to meet with JPMorgan »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ARCB

ArcBest

$48.40

1.05 (2.22%)

, BOFI

BofI Holding

$35.82

0.34 (0.96%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Stephens to hold a forum »

8th Annual Bank CEO Forum…

ARCB

ArcBest

$48.40

1.05 (2.22%)

BOFI

BofI Holding

$35.82

0.34 (0.96%)

BY

Byline Bancorp

$22.74

-0.07 (-0.31%)

CARO

Carolina Financial

$38.58

-0.22 (-0.57%)

CSFL

CenterState Bank

$28.99

(0.00%)

FBK

FB Financial

$41.37

-2.11 (-4.85%)

HTH

Hilltop Holdings

$20.69

0.13 (0.63%)

NBHC

National Bank

$37.79

0.04 (0.11%)

NCOM

National Commerce

$42.35

-0.35 (-0.82%)

OLBK

Old Line Bancshares

$32.07

-0.38 (-1.17%)

ICBK

County Bancorp

$25.61

0.11 (0.43%)

LION

Fidelity Southern

$25.13

-0.05 (-0.20%)

MSBI

Midland States

$32.60

-0.26 (-0.79%)

TBK

Triumph Bancorp

$40.25

-1.5 (-3.59%)

STL

Sterling Bancorp

$22.70

-0.05 (-0.22%)

VBTX

Veritex

$28.81

-0.08 (-0.28%)

WTFC

Wintrust Financial

$88.61

-0.49 (-0.55%)

TSC

TriState Capital

$27.60

-0.35 (-1.25%)

RNST

Renasant

$42.56

-0.49 (-1.14%)

SFNC

Simmons First National

$30.55

-0.15 (-0.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 08

    Oct

  • 23

    Oct

  • 29

    Oct

  • 05

    Nov

  • 06

    Nov

  • 07

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 05

    Dec

  • 06

    Dec

GE

General Electric

$11.27

-0.47 (-4.00%)

, SKI

American Skiing Company

$0.00

(0.00%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
William Blair to hold a tour »

New England Industrial…

GE

General Electric

$11.27

-0.47 (-4.00%)

SKI

American Skiing Company

$0.00

(0.00%)

KAI

Kadant

$107.10

-2.3 (-2.10%)

ROLL

RBC Bearings

$150.80

-0.35 (-0.23%)

ITT

ITT

$61.01

-0.175 (-0.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

WH

Wyndham Hotels & Resorts

$55.27

0.12 (0.22%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Wyndham Hotels & Resorts management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WTTR

Select Energy Services

$12.18

-0.05 (-0.41%)

04:55
09/26/18
09/26
04:55
09/26/18
04:55
Conference/Events
Select Energy Services management to meet with Stephens »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.